Pseudallescheria boydii in an immunocompromised host. Successful treatment with debridement and itraconazole.
Ruxin
T A
TA
Cleveland Clinic Foundation, OH, USA.
Steck
W D
WD
Helm
T N
TN
Bergfeld
W F
WF
Bolwell
B J
BJ
D000935:Antifungal Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D003646:Debridement; D005533:Foot Dermatoses / Q000382:microbiology* / Q000628:therapy; D006801:Humans; D016867:Immunocompromised Host; D017964:Itraconazole / Q000627:therapeutic use*; D015470:Leukemia, Myeloid, Acute / Q000150:complications; D008297:Male; D008875:Middle Aged; D008271:Mycetoma / Q000382:microbiology* / Q000628:therapy; D011541:Pseudallescheria / Q000302:isolation & purification
D000935:Antifungal Agents; D017964:Itraconazole